Clinical Trials

A Randomized Controlled Trial of Prostatak as Adjuvant to Up-Front Radiation Therapy of Localized Prostate Cancer


Study ID
Advantagene PrTK03

NCT Number
NCT01436968 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0221

Principle Investigator
Dr. Glen Gejerman

Sponsor
Advantagene


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now